Jordan vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin
Jordan
62
in 2021
Trinidad and Tobago
57
in 2021
Jordan rank
117th
Trinidad and Tobago rank
120th
The number of people with susceptibility test result for rifampicin over time
- Jordan
- Trinidad and Tobago
How they compare
Jordan currently reports 62 against 57 in Trinidad and Tobago, a difference of 5.
That makes Jordan's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Jordan ahead.
Jordan ranks 117th and Trinidad and Tobago ranks 120th of 155 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Trinidad and Tobago in 1.
Head to head by decade
| Decade | Jordan | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.33 | 102.67 | 18.33 | Trinidad and Tobago |
| 2020s | 86 | 74.5 | 11.5 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jordan or Trinidad and Tobago?
- Jordan, at 62 against 57 in Trinidad and Tobago as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jordan and Trinidad and Tobago?
- 5, with Jordan ahead.
- How many years of comparable data are there for Jordan and Trinidad and Tobago?
- 5 years are reported by both, from 2017 to 2021.
- How do Jordan and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
- Jordan ranks 117th and Trinidad and Tobago ranks 120th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.